ArticleJournal of neuropathology and experimental neurology2015

CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.

Gerald F Reis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.